Squamous Cell Lung Cancer Risk Is Associated with Rare, Pathogenic Germline Variants in BRCA2 and Fanconi Anemia Genes

被引:0
|
作者
Selvan, M. Esai
Klein, R.
Gumus, Z.
机构
[1] Icahn Sch Med Mt Sinai, Genet & Genom, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Icahn Inst Data Sci & Genom Technol, New York, NY 10029 USA
关键词
germline risk; Genomics; squamous lung cancer;
D O I
10.1016/j.jtho.2019.08.1089
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.11-16
引用
收藏
页码:S522 / S522
页数:1
相关论文
共 50 条
  • [1] Rare, Pathogenic Germline Variants in Fanconi Anemia Genes Increase Risk for Squamous Lung Cancer
    Selvan, Myvizhi Esai
    Klein, Robert J.
    Gumus, Zeynep H.
    CLINICAL CANCER RESEARCH, 2019, 25 (05) : 1517 - 1525
  • [2] Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis
    Blanche P. Alter
    Ana F. Best
    Breast Cancer Research and Treatment, 2020, 182 : 465 - 476
  • [3] Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis
    Alter, Blanche P.
    Best, Ana F.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (02) : 465 - 476
  • [4] Correction to: Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis
    Blanche P. Alter
    Ana F. Best
    Breast Cancer Research and Treatment, 2020, 183 : 491 - 491
  • [5] Pathogenic Germline Rare Variants and Risk of Lung Cancer
    Liu, Y.
    Mckay, J.
    Xiao, X.
    Field, J.
    Davies, M.
    Brennan, P.
    Liu, G.
    Hung, R. J.
    Christiani, D. C.
    Amos, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S689 - S690
  • [6] Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Pathogenic Variants in BRCA1 and BRCA2
    Phillips, Kelly-Anne
    Kotsopoulos, Joanne
    Domchek, Susan
    Chamberlain, James
    Bassett, Julie
    Aeilts, Amber
    Andrulis, Irene
    Buys, Saundra
    Cui, Wanda
    Daly, Mary
    Eisen, Andrea
    Foulkes, William
    Friedlander, Michael
    Gronwald, Jacek
    Hopper, John
    John, Esther
    Karlan, Beth
    Kim, Raymond
    Lubinski, Jan
    Metcalfe, Kelly
    Nathanson, Katherine
    Singer, Christian F.
    Symecko, Heather
    Tung, Nadine
    Narod, Steven
    Terry, Mary Beth
    Milne, Roger
    CANCER RESEARCH, 2024, 84 (09)
  • [7] Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis (vol 182, pg 465, 2020)
    Alter, Blanche P.
    Best, Ana F.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 183 (02) : 491 - 491
  • [8] A pathogenic germline BRCA2 variant in a patient with hypopharyngeal squamous cell carcinoma
    Correa, Tatiana
    Laux, Douglas E.
    Hoffman, Henry T.
    CLINICAL CASE REPORTS, 2021, 9 (01): : 429 - 432
  • [9] Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
    Li, Shuai
    Silvestri, Valentina
    Leslie, Goska
    Rebbeck, Timothy R.
    Neuhausen, Susan L.
    Hopper, John L.
    Nielsen, Henriette Roed
    Lee, Andrew
    Yang, Xin
    McGuffog, Lesley
    Parsons, Michael T.
    Andrulis, Irene L.
    Arnold, Norbert
    Belotti, Muriel
    Borg, Ake
    Buecher, Bruno
    Buys, Saundra S.
    Caputo, Sandrine M.
    Chung, Wendy K.
    Colas, Chrystelle
    Colonna, Sarah, V
    Cook, Jackie
    Daly, Mary B.
    de la Hoya, Miguel
    de Pauw, Antoine
    Delhomelle, Helene
    Eason, Jacqueline
    Engel, Christoph
    Evans, D. Gareth
    Faust, Ulrike
    Fehm, Tanja N.
    Fostira, Florentia
    Fountzilas, George
    Frone, Megan
    Garcia-Barberan, Vanesa
    Garre, Pilar
    Gauthier-Villars, Marion
    Gehrig, Andrea
    Glendon, Gord
    Goldgar, David E.
    Golmard, Lisa
    Greene, Mark H.
    Hahnen, Eric
    Hamann, Ute
    Hanson, Helen
    Hassan, Tiara
    Hentschel, Julia
    Horvath, Judit
    Izatt, Louise
    Janavicius, Ramunas
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (14) : 1529 - +
  • [10] The Contribution of Germline Pathogenic Variants in Breast Cancer Genes to Contralateral Breast Cancer Risk in BRCA1/BRCA2/PALB2-Negative Women
    Larionov, Alexey
    Fewings, Eleanor
    Redman, James
    Goldgraben, Mae
    Clark, Graeme
    Boice, John
    Concannon, Patrick
    Bernstein, Jonine
    Conti, David V.
    WECARE Study Collaborative Grp, Marc
    Tischkowitz, Marc
    CANCERS, 2023, 15 (02)